Online Courses for Physician Assistant

A complete listing of currently available online programs is provided below. To access course materials and claim credit you must be registered and logged-in. Courses of interest must be selected and added to your FCMCME.org user account. Once selected course material links will be provided from within your individual User Record section of this website.

Sort by: Title | Newest
Anticoagulation Reversal: Case 1 - Sensible Risk Stratification
Presented by: Peter J. Kudenchuk, MD
Effective Date: August 15, 2017
Expiration Date: August 14, 2019
Credits: .5
Format: Webinar
Fee: Free
16892

This interactive case study discussion will provide the knowledge and tools to enable the primary care provider to use scoring systems such as the CHADS-VASc,and HAS-BLED to stratify patients risk potential for bleeding due to anticoagulation therapy.

Case: A 40-year old male from the Xinjiang Province in China presents with ischemic stroke, category 4 on the LAMS (Los Angeles Motor Scale). He is a crewmember on a Chinese freighter offloading in a U. S. port city when he collapses and is rushed to a local hospital. The captain has no information on the crewmember’s medical history but notes that the patient is a heavy smoker and tends to binge drink when portside.

Outcome Objectives:

  • Utilize scoring systems (CHADS-VASc, HAS-BLED) to risk-stratify patients considered for anticoagulation therapies and mitigate their bleeding risk

Funded through an educational grant from Portola Pharmaceuticals Inc.

Selection Required to Claim Credit

Anticoagulation Reversal: Case 2 - Converting Between Anticoagulants
Presented by: Peter J. Kudenchuk, MD
Effective Date: August 15, 2017
Expiration Date: August 14, 2019
Credits: .5
Format: Webinar
Fee: Free
16893

This interactive case study discussion will provide the knowledge and tools to enable the primary care provider to explain the incidence and sources of bleeding related to the use of oral anticoagulants and its impact on health care; compare the difference in bleeding risk between oral vitamin K antagonists and direct oral anticoagulants (DOACs) and be able to convert from one anticoagulant to another.

Case: A 57-year old Alaska Native female has been taking Warfarin for several years for non-valvular AF and wishes to switch to one of the newer DOACs, which she hears are safer.

Outcome Objectives:

  • Explain the incidence and sources of bleeding related to the use of oral anticoagulants and its impact on health care.
  • Compare the difference in bleeding risk between oral vitamin K antagonists and direct oral anticoagulants (DOACs).
  • Describe a strategy for conversion from one anticoagulant to another

Funded through an educational grant from Portola Pharmaceuticals Inc.

Selection Required to Claim Credit

Anticoagulation Reversal: Case 3 - Reversing Anticoagulation
Presented by: Peter J. Kudenchuk, MD
Effective Date: August 15, 2017
Expiration Date: August 14, 2019
Credits: .5
Format: Webinar
Fee: Free
16894

This interactive case study discussion will provide the knowledge and tools to enable the primary care provider to understand the mechanism of anticoagulation and its reversal for oral vitamin K anticoagulants and the DOAC agents.

Case: An 82 year old male suffers a subdural hematoma after falling down a flight of concrete stairs. He is taking Warfarin. Past history remarkable for controlled HTN and diet-managed type 2 DM.

Outcome Objectives:

  • Characterize the mechanism of anticoagulation and its reversal for oral vitamin K anticoagulants and the DOAC agents

Funded through an educational grant from Portola Pharmaceuticals Inc.

Selection Required to Claim Credit

Anticoagulation Reversal: Case 4 - Stopping the Bleed - A 4 Step Approach
Presented by: Peter J. Kudenchuk, MD
Effective Date: August 15, 2017
Expiration Date: August 14, 2019
Credits: .5
Format: Webinar
Fee: Free
16895

This interactive case study discussion will provide the knowledge and tools to enable the primary care provider to understand the efficacy and limitations of current approaches to reversing anticoagulation in recipients of oral vitamin K antagonists and the mechanisms of the current reversal agents for DOACs and how they differ from approaches for reversal of vitamin K antagonists.

Case: A 59-year old male suffers a major GI bleed. He has been taking dabigatran for the past year for nonvalvular AF.

Outcome Objectives:

  • Describe the efficacy and limitations of current approaches to reversing anticoagulation in recipients of oral vitamin K antagonists
  • Characterize the mechanisms of the current reversal agents for DOACs and how they differ from approaches for reversal of vitamin K antagonists. 

Funded through an educational grant from Portola Pharmaceuticals Inc.

Selection Required to Claim Credit

Case Studies In Heart Failure
Presented by: Nicholas D. Wyatt, PharmD, Peter J. Kudenchuk, MD
Effective Date: February 01, 2017
Expiration Date: March 01, 2020
Credits: 2.5
Format: Webinar
Fee: $60.00
16749

Heart failure impacts the lives of thousands upon thousands of patients as well as their family members every year. The disease cost the healthcare system billions of dollars every year and is expected to continue to rise.

This course will give the participant the resources and tools necessary to become a heart failure expert. Our discussion will start with the epidemiology of heart failure. Then we will transition into discussing the stages of heart failure, specifically focusing on the four stages of heart failure and the evidence treatments of these four stages. Thanking you for joining me on your journey to becoming a heart failure expert. Let' get started.

Outcome Objectives
Upon completion of this CME/CE activity the healthcare provider will be able to:

  1. Describe the clinical epidemiology of heart failure and its impact on health care delivery and costs.
  2. List the modifiable risk factors of heart failure
  3. Identify the non-modifiable risk factors of heart failure
  4. Describe the population attribution risk of heart failure for modifiable and non-modifiable risk factors
  5. Define the four stages of the ACC/AHA heart failure staging model.
  6. Describe the four classification stages of the NYHA heart failure staging model.
  7. Describe the neurohormonal response in patients with and without heart failure.
  8. Identify key compensatory neurohormones in heart failure patients.
  9. Describe the renin-angiotension system response in patients with heart failure.
  10. List the compensatory responses that maintain circulation as a result of decreased cardiac output.
  11. Name two biomarkers used in the diagnosis and assessment heart failure.
  12. Discuss the four components of examining the heart failure patient.

To participate in this activity you must be Registered and Logged In to this website.

Selection Required to View & Claim Credit

Case Studies In Multiple Sclerosis: Taking A Fresh Look At A Complex Disease
Presented by: Pavle Repovic, MD, PhD
Effective Date: January 01, 2019
Expiration Date: January 01, 2020
Credits: 1.0
Format: Webinar
Fee: $15.00
17620

This program provides the knowledge and skills to primary care providers (PCPs) to enable them to correctly diagnose and treat multiple sclerosis (MS) and its co-morbidities for improved patient outcomes. It covers assessment protocols and diagnostic tests: pharmacologic, alternative, and complementary therapies; patient monitoring; and symptom management. Four case study discussions are presented in15 minute interactive, voice-over slides lectures. Two toolkits are available for download, one for the PCP and one for the patient.

Case One - Presenting Symtoms of Multiple Sclerosis:
Covers the essentials of the history and neurological exam and descriptions of symptoms of optic neuritis, transverse myelitis, and brainstem and cerebellar involvement.

Case Two - Current Diagnostic Tests:
Covers the current diagnostic tests, including lab and imaging, are presented and shown as well as major clinical red flags in diagnosis.

Case Three - Current Pharmacologic, Non-Pharmacologic Treatment Options:
Covers the common principles of MS therapy, injectables, oral medications, and IV infusions: their side effects, monitoring, and risks are discussed as well as disease-modifying therapies for relapsing remitting MS. Non-pharmacological treatment includes diet, exercise, and mental health.

Case Four - Patient Monitoring and Symptom Management:
Covers the managing motor and other symptoms (eg, bladder, fatigue, pain, and mood) as discussed. Use of the toolkits to help the patient to manage their own symptoms and find resources.

Selection Required to View & Claim Credit

Chronic Fatigue Syndrome and Hypothyroidism Are Linked To Low T3 Syndrome
Presented by: Neal Rouzier, MD
Effective Date: July 11, 2018
Expiration Date: July 11, 2020
Credits: 1.0
Format: Webinar
Fee: $30.00
17562

Dr. Rouzier, will be reviewing Chronic Fatigue Syndrome and how the signs and symptoms are similar, to hypothyroidism. How many times these conditions are misdiagnosed and how to interpret your patient's medical condition to improve clinical outcomes.

Outcome Objectives:
Upon completion of this CME/CE activity the healthcare provider will be able to:

  1. Review the work-up and diagnosis of Chronic Fatigue Syndrome.
  2. Recognize the many inflamed hormonal pathways in CFS.
  3. Discuss the pathophysiology involved in the development of CFS.
  4. Review thyroid lab tests as they pertain to CFS.
  5. Identify why it is called the hypometabolic syndrome.
  6. Review the studies that support normalizing TSH levels does NOT result in clinical euthyroidism.

To fully participate in this activity you must be Registered and Logged In to this website.

Selection Required to View & Claim Credit

Clinical Diagnosis and Treatment for Complex Female HRT Patients
Presented by: Ilona Bleaman, PA-C, MHPE
Effective Date: April 11, 2018
Expiration Date: April 11, 2020
Credits: 1.0
Format: Webinar
Fee: $15.00
17636

Women in their thirties well into their fifties commonly present to the office complaining of fatigue, weight gain, insomnia, irritability, acne, hair loss and decreased libido. Whether the patient is complaining of one or all of the above it is apparent that her quality of life is being affected. Many of these symptoms are frequently related to an imbalance or declining of their hormones.

Upon closer examination and analysis of patients’ prior lab work compared with current blood results it became apparent that often times only symptoms are being treated and not the underlying cause. For example, a 38 year old female with acne is commonly prescribed spironolactone yet the underlying origin or disease process, Polycystic Ovary Syndrome, is not identified or addressed. Additionally, perimenopausal women are often misdiagnosed and then prescribed inappropriate hormone regimens that result in an increase or new symptoms.

The intention of this webinar is to highlight and review a variety of cases with atypical patient presentations focusing on perimenopause and Polycystic Ovary Syndrome. The webinar identifies patients’ chief complaints and discusses their lab results. With this information an appropriate treatment plan is then developed. Practical clinical pearls are identified throughout the presentation.

To fully participate in this activity you must be Registered and Logged In to this website.

Selection Required to View & Claim Credit

Diabetes Mellitus: Detecting and Treating Type 1 & 2 Patients In a Type 2 Global Epidemic
Presented by: Lorena Alarcon-Casas Wright, MD
Effective Date: January 01, 2019
Expiration Date: January 01, 2020
Credits: 1.0
Format: Webinar
Fee: $10.00
17671

The program goal is to provide primary care providers with up-to-date knowledge and tools to correctly diagnose and differentiate patients with Type 1 vs Type 2 Diabetes and treat them appropriately for better patient outcomes.

Outcome Objectives
Upon completion of this CME activity the healthcare provider will be able to:

  1. Identify the new glycemic goal targets for patients, and how best to achieve these goals
  2. Identify the most recent developments in therapeutics for Type II Diabetes (T2DM).
  3. Identify the less common Type I Diabetic in an epidemic of Type II.
  4. Apply the measures that can help prevent progression to T2DM in patients at risk.
  5. Implement the use of Toolkits to improve patient outcomes.

Selection Required to View & Claim Credit

Endobronchial Ultrasonography: A Practical Approach
Presented by: Gustavo Cumbo Nacheli, MD FCCP DAABIP, John Egan III, MD FCCP DAABIP
Effective Date: February 01, 2019
Expiration Date: January 31, 2021
Credits: 1.0
Format: Webinar
Fee: $15.00
17771

Society for Advanced Bronchoscopy (SAB) Archived Presentation January 2019

Often times first step on workup for intrathoracic abnormalities involve transthoracic sample acquisition. Understanding correct EBUS application and patient section are key to perform the correct procedure and expedites proper treatment.

At the conclusion of the webinar, the learner should have gained an enhanced understanding of intrathoracic lymph node anatomy, sampling techniques, and clinical usefulness of various endobronchial ultrasound guided diagnostic approaches; thereby improving patient outcomes.

Following the presentation questions from the audience were addressed in a moderated Q&A session.

Selection Required to View & Claim Credit

Heart Failure: What the Primary Care Provider Needs to Know for Better Patient Outcomes
Presented by: Peter J. Kudenchuk, MD
Effective Date: September 06, 2016
Expiration Date: September 06, 2019
Credits: 1.0
Format: Webinar
Fee: $15.00
16455

The goal of this course is to provide the knowledge and tools to equip the Primary Care Provider, Pharmacist and Other Health Care Providers to improve the health status of patients with Heart Failure. It includes an audience participated Q&A session and ends with a description of a 20 credit hour Performance Improvement Project and an invitation and instructions to enroll in this project without cost.

Outcome Objective
Upon completion of this CME/CE activity the healthcare provider will be able to:

  1. Describe the clinical epidemiology of heart failure and its impact on health care delivery and costs.
  2. Distinguish heart failure with reduced left ventricular function from heart failure with preserved ventricular function.
  3. Explain the pathophysiological processes that occur to create clinical heart failure and promote its progression.
  4. Identify pharmacological and non-pharmacologic approaches to treating patients with heart failure and a step-wise approach to their implementation.
  5. Utilize the provider and patient toolkits to better educate patients about this condition and steps they can take to avoid it for better health outcomes.

Selection Required to View & Claim Credit

Opioid Addiction: Challenging Cases in Diagnosis, Treatment, and Prevention
Presented by: Christine Mintz, MD
Effective Date: June 19, 2018
Expiration Date: June 19, 2020
Credits: 1.0
Format: Webinar
Fee: $15.00
17299

It is estimated that each day more than 1000 people are treated in emergency departments for not using prescription opioids as prescribed. Combine this with illicit drug use and the cost of treatment and productivity losses related to addiction and we have a current epidemic costing Americans over 500 billion dollars and rising.

This interactive course will give the participant the resources and tools necessary to identify, educate and treat opioid tolerant and opioid addicted patients in primary care. We will cover the pathophysiology of opioids and their receptors, then we will transition to discussing tolerance vs. withdrawal and addiction. We will also review overdose antagonist medications, medication assisted treatments as well as briefly discuss new treatments and research on the horizon.

Outcome Objectives:
Upon completion of this CME/CE activity the healthcare provider will be able to:

  1. Describe the pathophysiology of opioid receptors in the dopamine reward pathway and how different opioids and opioid antagonists interact and bind to these receptors.
  2. Describe the common clinical features of chronic opioid abuse and suspected opioid withdrawal including appropriate diagnostic work-up.
  3. Discuss the current best practice treatment options for suspected opioid overdose including routes of administration and formulations as well as medication assisted treatment options.
  4. Identify new or emerging areas of research and treatment options for opioid dependence including pharmacologic and psychosocial strategies.

To fully participate in this activity you must be Registered and Logged In to this website.

Selection Required to View & Claim Credit